Controlled Non-Blinded Trial

Title Average Ratingsort ascending
Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer 100.00%
Determination of the Effectiveness of Chlorine Dioxide in the Treatment of COVID 19 100.00%
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study 90.00%
Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial 90.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy) 80.00%
Post Exposure Prophylaxis with Hydroxychloroquine (HCQ) for the Prevention of COVID-19, a Myth or a Reality? The PEP-CQ Study 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. 70.00%
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and re 70.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
The association between degenerative hip joint pathology and size of the gluteus medius, gluteus minimus and piriformis muscles. 60.00%
Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolera 50.00%
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung 50.00%
Adjuvante simultane Mistel-/Chemotherapie bei Mammakarzinom – Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit 50.00%
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofe 50.00%
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance—Nine States, June–August 2021 30.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%